Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Check out some of our latest original content that was created and distributed as part of our ongoing collaborations with IR firms and other companies.

HeartBeam Inc.’s (NASDAQ: BEAT) Two New U.S. Patents Power Next Generation of Cardiac Diagnostics

  • Two newly issued patents mark a strategic advancement in HeartBeam’s proprietary technology.
  • The first patent protects the company’s credit card–sized, cable-free 3D ECG device designed to capture high-fidelity electrical signals from three noncoplanar directions.
  • The second patent covers the company’s rhythm analysis algorithm by continuously analyzing signal input.

HeartBeam (NASDAQ: BEAT), a cardiac technology company, has secured two new U.S. patents that significantly enhance its intellectual property portfolio and strengthen its position in cardiac monitoring technology (https://ibn.fm/6xni4). The company, focused on delivering powerful, personalized insights into heart health through its innovative 3D ECG platform, now holds more than 20 U.S. and international patents, with additional applications pending.

The newly issued patents mark a strategic advancement in HeartBeam’s proprietary technology. The first patent protects the company’s credit card–sized, cable-free 3D ECG device designed to capture high-fidelity electrical signals from chest and finger electrodes in three noncoplanar directions. This portable device enables users to record their cardiac symptoms in real-time and synthesizes the recordings into a familiar 12-lead ECG reading through a personalized transformational matrix. The 12-led ECG synthesis software is now under FDA review, supported by data from the VALID-ECG pivotal study (https://ibn.fm/flaAR).

The second patent covers the company’s rhythm analysis algorithm, which classifies heart rhythms such as sinus rhythm, atrial fibrillation and other arrhythmias, by continuously analyzing signal input. Designed for integration with any cardiac monitoring system, including wearables, it provides on-device, risk-based escalation by detecting anomalies and prompting users to record high-fidelity 3D ECG signals for 12-lead synthesis. HeartBeam plans to submit the rhythm analysis algorithm for FDA clearance in the future.

“HeartBeam’s vision is to make it easier for patients and physicians to monitor and diagnose cardiac symptoms outside of a medical facility,” said HeartBeam CEO Robert Eno. “The new patents add to our growing IP portfolio, enabling us to expand the reach and impact of our groundbreaking 3D ECG technology as we strive to transform the future of cardiac care.”

These patents significantly bolster the defensive moat around HeartBeam’s core technology, enabling future product extensions in areas such as AI-driven arrhythmia classification and ischemia detection. Their addition brings the company’s IP holdings to more than 20 issued U.S. and international patents, 2 allowed patents and 32 pending applications.

BEAT’s platform centers on its proprietary 3D ECG technology, which collects the heart’s electrical signals in three distinct noncoplanar directions and transforms those signals into synthesized 12-lead ECGs. This platform technology is designed for use in a range of form factors, including credit card–sized monitors, extended-wear patches and wrist-worn devices. This transformative approach empowers physicians to monitor patients remotely and direct them to appropriate care outside traditional medical facilities.

HeartBeam’s broadened patent portfolio may strengthen investor confidence by positioning the company securely in a highly competitive medical device landscape. A robust IP framework is a critical asset in the system of portable devices aimed at transforming cardiac care delivery. As HeartBeam moves toward broader clinical adoption and regulatory milestones, the two newly issued patents offer added protection and commercialization leverage. They lay the groundwork for future enhancements while strengthening partnerships and facilitating market access.

For more information, visit HeartBeam.com.

NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://ibn.fm/BEAT

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in HeartBeam Inc. BEAT | Leave a comment

MissionIRNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Prevails in Final Legal Challenge for El Domo Environmental License

Silvercorp Metals (TSX: SVM) (NYSE American: SVM) announced that Ecuador’s Constitutional Court unanimously rejected a final legal challenge against the environmental license for the El Domo mining project, confirming its validity. El Domo, now under construction, is the first mining project in Ecuador to complete an environmental consultation aligned with the Escazú Agreement’s standards. The license was backed by 98% of the local population and has been upheld by multiple judicial levels, including the Constitutional Court. Despite continued obstruction efforts by anti-mining groups, project development remains on track.

To view the full press release, visit https://ibn.fm/11dUf

About Silvercorp

Silvercorp is a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability and growth potential. The Company’s strategy is to create shareholder value by 1) focusing on generating free cash flow from long life mines; 2) organic growth through extensive drilling for discovery; 3) ongoing merger and acquisition efforts to unlock value; and 4) long term commitment to responsible mining and ESG.

NOTE TO INVESTORS: The latest news and updates relating to SVM are available in the company’s newsroom at https://ibn.fm/SVM

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Silvercorp Metals Inc. SVM | Leave a comment

Nutriband Inc. (NASDAQ: NTRB) Aligns Shareholder Value with FDA Milestone

  • FDA approval is a powerful inflection point in the lifecycle of any biopharmaceutical company 
  • Nutriband’s recent 25% preferred stock dividend uniquely ties shareholder reward to regulatory achievement
  • CEO notes that “core goal is to continue to create value for our shareholders particularly as we near closer to the commercialization of AVERSA(TM) Fentanyl”

Obtaining approval from the U.S. Food and Drug Administration (“FDA”) is a monumental achievement for any biopharmaceutical company, serving as a critical validation of a drug’s safety and efficacy. This rigorous process is a cornerstone of public health, ensuring that only treatments proven to be beneficial and with acceptable risks reach patients. Recognizing the immense value this milestone represents, Nutriband (NASDAQ: NTRB) recently underscored its commitment to this pathway by announcing a 25% preferred stock dividend as the company targets filing for FDA approval for its lead product, AVERSA(TM) Fentanyl (https://ibn.fm/8FRUA).

FDA approval is a powerful inflection point in the lifecycle of any biopharmaceutical company. Recent research published in “Drug Discovery Today” examined biotech firms that received FDA Fast Track designation between 2019 and 2020 and found average cumulative abnormal returns (“CAR”) of 21.6% over five days, 38.3% over 30 days, 76.6% after one year, and an impressive 111% over three years, highlighting the long-term investor confidence triggered by regulatory milestones (https://ibn.fm/L51Jp).

Approval not only unlocks revenue streams, but it also legitimizes a company’s technology in the eyes of regulators, insurers and prescribers and can play a crucial role in facilitating downstream opportunities such as commercial manufacturing partnerships and product integration into healthcare systems. For Nutriband, whose Aversa technology integrates aversive agents into fentanyl patches to deter abuse, approval is indispensable for scaling manufacturing agreements, similar to the one it currently has with Kindeva Drug Delivery (https://ibn.fm/3YRfX), and executing its business plan. Additionally, approved status is often the trigger for a variety of financing mechanisms, from venture rounds to licensing deals. offering new capital and strategic flexibility. 

Nutriband’s recent 25% preferred stock dividend — one preferred share for every four common shares held, with a record date of July 25 and payment scheduled for August 5 — uniquely ties shareholder reward to regulatory achievement. These preferred shares will automatically convert into common stock upon FDA approval of Aversa. If not converted, they will yield annual cash dividends tied to company profitability, reinforcing Nutriband’s pledge to distributor shareholder value. 

“Our core goal is to continue to create value for our shareholders particularly as we near closer to the commercialization of AVERSA(TM) Fentanyl,” said Nutriband CEO Gareth Sheridan. “We recently highlighted our commercialization manufacturing process scale up with Kindeva, and we are now laser focused on finalizing our development pathway to FDA approval.”

Founded with a focus on abuse-deterrent transdermal patches, Nutriband has progressed major milestones swiftly. The company’s Aversa patch incorporates aversive agents into fentanyl patches to prevent misuse and accidental exposure. The company has built a global IP protection strategy, securing patents across the United States, Europe, Asia and Australia. With commercialization manufacturing scaled up in collaboration with Kindeva, Nutriband is poised for submission to the FDA, potentially initiating a transition that would unlock major revenue opportunities. A preferred dividend tied to FDA approval crystallizes the company’s dual aim: incentivize shareholders now while targeting near-term regulatory proof points.

With its innovative technology, robust IP, scaled manufacturing plan and shareholder-friendly dividend structure, Nutriband is crafting a compelling narrative for the biotech world —and Wall Street. As other biotechs recalibrate their financial structures to support milestone-focused value delivery, Nutriband has taken an early lead. 

For more information, visit the company’s website at www.Nutriband.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRB are available in the company’s newsroom at https://ibn.fm/NTRB

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Nutriband Inc. NTRB | Leave a comment

MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Secures Continuation Patent for Gesture and Voice-Control Interface

Wearable Devices (NASDAQ: WLDS, WLDSW), a technology company specializing in AI-powered touchless sensing wearables, announced the issuance of a continuation patent by the U.S. Patent and Trademark Office, expanding its foundational patent titled “Gesture and Voice-Controlled Interface Device.” The patent enhances protection for the company’s neural interface technologies by introducing a method to identify start and end points of continuous gestures, enabling intuitive control without physical contact or voice triggers. This innovation addresses limitations in traditional gesture and voice systems and supports applications in XR headsets, smart devices, and EMG-based wearables. President and Chief Scientific Officer Guy Wagner said the patent strengthens the company’s gesture recognition engine and advances its mission to create seamless digital interaction.

To view the full press release, visit https://ibn.fm/6NtVN

About Wearable Devices Ltd.

Wearable Devices Ltd. is a pioneering growth company revolutionizing human-computer interaction through its AI-powered neural input technology for both consumer and business markets. Leveraging proprietary sensors, software, and advanced AI algorithms, the Company’s innovative products, including the Mudra Band for iOS and Mudra Link for Android, enable seamless, touch-free interaction by transforming subtle finger and wrist movements into intuitive controls. These groundbreaking solutions enhance gaming, and the rapidly expanding AR/VR/XR landscapes. The Company offers a dual-channel business model: direct-to-consumer sales and enterprise licensing. Its flagship Mudra Band integrates functional and stylish design with cutting-edge AI to empower consumers, while its enterprise solutions provide businesses with the tools to deliver immersive and interactive experiences. By setting the input standard for the XR market, Wearable Devices is redefining user experiences and driving innovation in one of the fastest-growing tech sectors. Wearable Devices’ ordinary shares and warrants trade on the Nasdaq under the symbols “WLDS” and “WLDSW,” respectively.

NOTE TO INVESTORS: The latest news and updates relating to WLDS are available in the company’s newsroom at https://ibn.fm/WLDS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Wearable Devices Ltd. WLDS | Leave a comment

Safe Pro Group Inc.’s (NASDAQ: SPAI) Drone-Based AI Tech Selected for Next Year’s U.S. Army Futures Command Experiment

  • The company will participate in the U.S. Army’s CFWE-M 2026 modernization experiment at Fort Benning, where it will showcase its SpotlightAI(TM) platform.
  • SpotlightAI detects explosive threats from drone imagery in near real-time. It has been trained on over 1.6 million drone images from Ukraine and has identified more than 28,000 threats to date.
  • The company is working to integrate the system into the Army’s TAK ecosystem to deliver instant alerts to soldier-carried devices.
  • Safe Pro leverages off-the-shelf drones combined with its patented AI to reduce the risk and time required for explosive threat detection.

Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, will demonstrate its drone-based artificial intelligence tools during the U.S. Army’s 2026 Concept Focused Warfighting Experiment Maneuver (“CFWE-M”), scheduled for March and April 2026 at Fort Benning, Georgia (https://ibn.fm/CfLw3).

The event, hosted by the Army Futures Command (“AFC”), is part of the service’s broader push to modernize small unit capabilities. Established in 2018, the AFC is charged with ensuring the Army remains competitive in a rapidly evolving military technology landscape. CFWE-M supports small unit modernization by providing Army collaboration opportunity to Cross Function Teams (“CFT”), Centers of Excellence (“CoE”) capability developers, Science and Technology (“S&T”) community, and industry representatives.

Safe Pro will use the opportunity to present its SpotlightAI(TM) system, a patented platform that rapidly processes drone imagery using AI and computer vision to detect and classify over 150 types of landmines and unexploded ordnance (“UXO”). According to Safe Pro’s announcement, the tool analyzes each image in less than a second, providing fast and accurate threat explosive identification capabilities.

The company’s selection for CFWE-M builds on nearly three years of real-world data gathered in Ukraine. There, Safe Pro has analyzed more than 1.66 million high-resolution drone images, identifying over 28,000 threats across more than 6,700 hectares. This real-world dataset has helped improve the accuracy and reliability of its detection algorithms.

“We are honored to be selected to participate in this important Army event to demonstrate how our battle-tested AI technology enhances modern force protection,” said Dan Erdberg, chairman and CEO of Safe Pro Group. “As drone warfare continues to evolve, we are well positioned to provide the warfighter with novel algorithms producing rapid, actionable intelligence on the battlefield.” 

Participation in the CFWE-MA is one of a number of efforts the company is taking as it seeks to penetrate the U.S. Department of Defense where it is working to integrate with the U.S. Army’s Android Tactical Assault Kit (“ATAK”) platform. ATAK is widely deployed across the military and allows soldiers to share geospatial and threat data through mobile devices. Safe Pro’s AI-powered alerts, generated from drone footage, can be relayed across this network, reaching soldiers and vehicle systems equipped with ATAK-connected hardware.

The Company’s solution uses commercially available, off-the-shelf drones, making the technology more accessible and cost-efficient than custom hardware-based systems. Once the drone imagery is collected, Safe Pro’s machine learning algorithms scan the data to detect threats in real time before feeding alerts into defense communications platforms like ATAK. Utilizing a cloud-based environment, powered by Amazon Web Services (“AWS”), Safe Pro’s system can create realistic 2D and interactive 3D maps highlighting objects of interest to provide valuable insights for mission planning and force protection.

Beyond military applications, Safe Pro says it is targeting law enforcement, humanitarian response, and homeland security markets. Its platforms, including AI-powered computer vision technology for situational awareness also include Airborne Response for drone-based services for critical infrastructure and law enforcement, that operates as part of a broader defense ecosystem that also includes ballistic protective gear under the Safe-Pro USA brand.

For more information, visit the company’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Safe Pro Group Inc. SPAI | Leave a comment

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Is ‘One to Watch’

  • Trilogy Metals holds a 50% interest in the UKMP, a 471,796-acre (190,929-hectare) land package hosting two high-grade undeveloped copper deposits.
  • The Arctic Project delivers robust feasibility-stage economics with an after-tax NPV of $1.1 billion and grades exceeding 4% copper equivalent.
  • The adjacent Bornite Project contains 6.5 billion pounds of inferred copper and can extend the district’s mine life to over 30 years.
  • Trilogy benefits from strategic partnerships with South32, NANA Regional Corporation, and the State of Alaska, bolstering its financial strength and permitting outlook.
  • The company operates in a top-tier jurisdiction for mining investment and is led by a seasoned executive team with decades of industry experience.

Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) is a North American mineral exploration and development company focused on advancing high-grade copper and critical mineral assets in Alaska. The company operates through Ambler Metals LLC, a 50/50 joint venture with South32 Ltd., and is progressing one of the world’s most prospective undeveloped polymetallic districts.

Trilogy is uniquely positioned with exposure to copper, zinc, lead, cobalt, silver, and gold—commodities vital to global electrification and energy transition. Its vision is to responsibly develop the Ambler Mining District into a premier domestic source of critical minerals while delivering long-term value to shareholders and local communities.

The company is guided by values of trust, respect, integrity, and partnership, and works closely with Alaska Native stakeholders to advance its strategy in a sustainable and inclusive manner.

Projects

Arctic Project

The Arctic project is Trilogy’s flagship asset and one of the highest-grade known copper deposits in the world, with an average grade of approximately 5% copper equivalent. Located roughly 470 kilometers northwest of Fairbanks, Alaska, Arctic is a volcanogenic massive sulphide (“VMS”) deposit hosting copper, zinc, lead, gold, and silver. The project is at the feasibility stage and is currently undergoing permitting activities.

According to the 2023 Feasibility Study, Arctic will support a 10,000 tonne-per-day open-pit mining operation over a 13-year mine life. Based on long-term metal prices of $3.65/lb copper, $1.15/lb zinc, $1.00/lb lead, $1,650/oz gold, and $21.00/oz silver, the project demonstrates a pre-tax NPV8% of $1.5 billion and an IRR of 25.8%. After-tax, the NPV8% is $1.1 billion with a 22.8% IRR. At April 2025 spot metal prices, the after-tax NPV8% increases to $1.9 billion with a 31.1% IRR.

The project’s metallurgy supports high recoveries: 92.1% for copper, 88.5% for zinc, and 61.3% for lead. Life-of-mine payable production is projected to total 1.9 billion pounds of copper, 2.2 billion pounds of zinc, 335 million pounds of lead, 423,000 ounces of gold, and 36 million ounces of silver. Cash costs are expected to average $0.72 per pound of payable copper, with all-in costs estimated at $1.61 per pound.

Bornite Project

Located approximately 25 kilometers southwest of Arctic, the Bornite project is a large-scale carbonate replacement copper deposit with significant upside. According to the 2025 Preliminary Economic Assessment (“PEA”), Bornite is expected to support a 6,000 tonne-per-day underground operation over a 17-year mine life, using re-purposed infrastructure from the Arctic Project.

Bornite contains an estimated 6.5 billion pounds of inferred copper. The PEA outlines pre-tax NPV8% of $552.1 million and IRR of 23.6%, with an after-tax NPV8% of $393.9 million and IRR of 20.0%, based on a copper price of $4.20/lb. Total payable copper production over the life of mine is projected at 1.9 billion pounds.

Bornite’s mineralization occurs in stacked, stratabound zones rich in chalcopyrite, bornite, and chalcocite. A subset of the South Reef zone offers high-grade underground mining potential, further enhancing Bornite’s future optionality.

Exploration Pipeline

The Upper Kobuk Mineral Projects span 471,796 acres and include more than 30 additional mineralized prospects beyond Arctic and Bornite. These lie along two geologically distinct and highly mineralized belts: the Ambler Schist Belt and the Bornite Carbonate Sequence.

The Ambler Schist Belt features multiple VMS-style prospects along its 100-kilometer strike length, including Sunshine, Snow, Nora, Shungnak, and BT. Neighboring deposits like Smucker (“Teck”) and Sun (“Valhalla Metals”) affirm the district’s regional potential. Ten of Trilogy’s VMS prospects have been drill tested with encouraging results.

Meanwhile, the Bornite Carbonate Sequence extends 16 kilometers along the Cosmos Hills and hosts additional targets such as Pardner Hill and Aurora Mountain. These zones show strong signs of copper and cobalt mineralization and were partially tested during the Kennecott era, suggesting significant room for expansion.

Together, these assets form the foundation of a multi-decade development and discovery platform in one of the most prospective undeveloped mining districts in North America.

Market Opportunity

Trilogy Metals is poised to benefit from long-term structural demand for copper and other critical minerals essential to electrification, energy infrastructure, and clean technologies. Copper, in particular, is expected to see major supply shortfalls due to underinvestment and accelerating demand from power grids, EVs, and data centers.

According to a Grand View Research report, the global copper market is projected to grow from $241.88 billion in 2024 to $339.95 billion by 2030, at a CAGR of 6.5%, driven by the energy transition and rising infrastructure investments.

Trilogy’s Arctic and Bornite projects are strategically located in Alaska, a top-tier mining jurisdiction with strong permitting frameworks and growing federal and state-level support, including recent executive orders streamlining approvals for the Ambler Access Project. The company also maintains a $50 million shelf prospectus and an active $25 million ATM equity program to fund future development.

Leadership Team

Tony Giardini, President and Chief Executive Officer, leads Trilogy Metals with extensive executive experience in the mining industry. He previously served as President of Ivanhoe Mines Ltd., and as Executive Vice President and Chief Financial Officer at Kinross Gold Corporation. Earlier in his career, he held senior roles at Placer Dome Inc. and KPMG. Mr. Giardini is both a Chartered Professional Accountant and a Certified Public Accountant.

Elaine M. Sanders, Chief Financial Officer and Corporate Secretary, brings over 25 years of financial and accounting experience to Trilogy. She is responsible for the company’s financial reporting, compliance, and governance functions. Ms. Sanders has overseen multiple financings and exchange listings throughout her career. She holds a Bachelor of Commerce from the University of Alberta and is both a Chartered Professional Accountant and Certified Public Accountant.

Richard Gosse, Vice President, Exploration, is a veteran geologist with 35 years of global exploration experience. He previously led exploration initiatives at Dundee Precious Metals and Ivanhoe Mines Ltd., where he oversaw the discovery efforts at the renowned Oyu Tolgoi copper-gold project in Mongolia. Mr. Gosse holds a B.Sc. in Geology from Queen’s University and an M.Sc. in Mineral Exploration from Imperial College London.

For more information, visit the company’s website at https://trilogymetals.com.

NOTE TO INVESTORS: The latest news and updates relating to TMQ are available in the company’s newsroom at https://ibn.fm/TMQ

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Trilogy Metals Inc. TMQ | Leave a comment

MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, has filed a Citizen Petition with the FDA requesting the removal of Benzethonium Chloride (BZT) from all ketamine products sold in the U.S. BZT, a quaternary amine preservative, is not Generally Recognized as Safe (GRAS) for parenteral use or Generally Recognized as Safe and Effective (GRASE) for topical use, and has demonstrated toxicity to epithelial cells and nerves. NRx previously submitted an Abbreviated New Drug Application for a preservative-free ketamine formulation with three-year room temperature stability and sterility, supported by a newly filed patent. The company is also pursuing a labeled indication for suicidal depression under the FDA Commissioner’s National Priority Voucher Program. CEO Dr. Jonathan Javitt noted that ketamine’s current use in treating conditions like suicidal depression and PTSD exposes patients to a preservative banned in other applications, aligning the petition with federal efforts to eliminate toxic additives from the drug supply.

To view the full press release, visit https://ibn.fm/dh9jk

About NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx plans to file an NDA for Accelerated Approval for NRX-101 in patients with bipolar depression and suicidality or akathisia. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently initiated a New Drug Application filing for NRX-100 (IV ketamine) for the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

NOTE TO INVESTORS: The latest news and updates relating to NRXP are available in the company’s newsroom at https://ibn.fm/NRXP

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Small Cap News | Leave a comment

MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Unveils AI Tool to Predict Blood-Brain Barrier Permeability with 94% Accuracy

Lantern Pharma (NASDAQ: LTRN), an AI-driven oncology drug development company, has launched predictBBB.ai(TM), a public AI module that predicts blood-brain barrier (BBB) permeability of small molecules with 94% accuracy, 95% sensitivity, and 89% specificity. Built on billions of molecular data points from Lantern’s proprietary data lake, the platform addresses the pharmaceutical challenge that only 2–6% of small molecules can cross the BBB. PredictBBB.ai(TM) ranks among the top performers on the Therapeutic Data Commons Leaderboard, leveraging synthetic data augmentation and advanced molecular representation to process compounds in real time. The launch comes as the BBB technologies market is projected to grow from $1.4 billion in 2023 to $9.85 billion by 2032, underscoring strong clinical demand.

To view the full press release, visit https://ibn.fm/eYg7n

About Lantern Pharma

Lantern Pharma (NASDAQ: LTRN) is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Our proprietary AI and machine learning (ML) platform, RADR(R), leverages over 100 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, we have accelerated the development of our growing pipeline of therapies that span multiple cancer indications, including both solid tumors and blood cancers and an antibody-drug conjugate (ADC) program. Our lead development programs include a Phase 2 clinical program and multiple Phase 1 clinical trials. Our AI-driven pipeline of innovative product candidates is estimated to have a combined annual market potential of over $15 billion USD and have the potential to provide life-changing therapies to hundreds of thousands of cancer patients across the world.

NOTE TO INVESTORS: The latest news and updates relating to LTRN are available in the company’s newsroom at https://ibn.fm/LTRN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Lantern Pharma Inc. LTRN | Leave a comment

PowerBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103): Name Change Signals Broader Energy Strategy and Investor Growth Potential

  • SolarBank Corporation has changed its name to PowerBank Corporation to better align with its expanding clean energy portfolio.
  • PowerBank develops solar and battery storage projects in the U.S. and Canada.
  • The firm holds a project pipeline exceeding one gigawatt and a built project base of 100 MW.
  • A recently announced $100 million financing with CIM Group is set to accelerate U.S. project construction.
  • U.S. tax incentives and Canadian contract programs position the company for stable growth and investor appeal.

Disseminated on behalf of PowerBank Corporation

SolarBank Corporation, a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S., is now PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103), a move that underscores the company’s evolving business model and its role in powering the digital economy. The name change, effective July 28, 2025, was approved by shareholders and reflects a strategic shift from a solar-centric identity toward a broader energy infrastructure platform (https://ibn.fm/CDCjI). 

Trading under the same stock tickers, the newly renamed PowerBank Corporation aims to clarify its market position as a provider of diversified clean energy solutions, including solar and battery storage. No changes were made to the company’s share capital, and shareholders are not required to take action. Share certificates remain valid under the new name. The rebranding comes as PowerBank deepens its operations across North America, with an active development pipeline exceeding 1 gigawatt and a built project capacity of over 100 megawatts.

PowerBank’s model includes selling electricity to utilities, municipalities, commercial entities, and residential off-takers through both direct and community solar contracts. The company is also scaling its Battery Energy Storage Systems (“BESS”), enabling it to tap into demand for dispatchable power and grid flexibility.

In the United States, the firm’s growth opportunities remain with the recently enacted “Big Beautiful Bill,” which offers full investment tax credits (“ITCs”) for solar and battery projects that begin construction before July 4, 2026, and come online within four years. This creates a finite window of opportunity for project developers, and PowerBank appears well-positioned to capitalize. CEO Richard Lu said the company has multiple advanced-stage U.S. projects eligible for the ITC benefits, with construction readiness already in motion.

A critical catalyst for near-term growth is the company’s recently announced $100 million project-level financing deal with CIM Group. The funding will support construction of a 97-megawatt U.S. solar portfolio, primarily concentrated in regions where PowerBank already holds permits and interconnection approvals. This arrangement gives the company the financial runway to convert development assets into operating projects, a key milestone for revenue generation and longer-term asset ownership.

PowerBank continues to pursue Canadian opportunities. In Ontario, the firm is advancing battery storage projects through the IESO Long-Term RFP program, which offers 10-year contracts for clean, dispatchable energy. In Nova Scotia, the company holds a sizable share of the province’s Community Solar program, positioning it to participate in both current and upcoming capacity rounds.

For more information, visit the company’s website at https://PowerBankCorp.com/. This report contains forward-looking information. Please refer to the press release entitled “SolarBank Issues Update on Strategic Positioning Amid Shifting U.S. and Canadian Policy Landscape” and dated July 10, 2025, for additional details on the information, risks and assumptions.

NOTE TO INVESTORS: The latest news and updates relating to SUUN are available in the Company’s newsroom at https://ibn.fm/SUUN

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in SolarBank Corp. SUUN | Leave a comment

Wearable Devices Ltd. (NASDAQ: WLDS) Is ‘One to Watch’

  • Wearable Devices holds a first-mover advantage in AI-powered neural input wearables, with validation from CES Innovation Awards and early adoption in key markets.
  • The company operates a dual-channel strategy that targets both consumer product sales and enterprise licensing opportunities.
  • Strategic partnerships with Qualcomm, TCL-RayNeo(TM), and Media Exceed support the company’s efforts to scale commercialization globally.
  • Its expanding patent portfolio includes recent U.S. approvals for gesture-based and hybrid voice control technologies, reinforcing its competitive edge.
  • With active initiatives in XR, spatial computing, and predictive health monitoring, the company is positioned to benefit from multiple high-growth sectors.

Wearable Devices (NASDAQ: WLDS) is a growth-stage technology company pioneering the next generation of human-computer interaction through AI-powered neural input wearables. Mudra, its proprietary wrist-worn technology, enables touchless, gesture-based control of digital devices, offering users a seamless, intuitive interface through subtle finger and hand movements. Since introducing its technology to the market in 2014, the company has pursued both business-to-business (B2B) and business-to-consumer (B2C) strategies through a dual-channel model.

The company believes the future of technology should begin with the human. Wearable Devices envisions decoding the human body to enable context-aware AI-powered technology that listens, learns, and adapts – to us.

The company envisions a future where human intent becomes the language of technology. Through non-invasive neural sensing and adaptive algorithms, the company enables more natural, personalized, and intuitive interactions with computers.

The company is headquartered in Yokneam Illit, Israel.

Products

Neural control has entered the market: commercially available since 2023 with the Mudra Band and already used by thousands of users worldwide. With its product line, including Mudra Band and Mudra Link, the company has introduced the world’s first wrist-worn neural interfaces, enabling intuitive, touchless control through natural micro-gestures: subtle finger movements and wrist flicks. Whether streaming media, controlling smart devices, or interacting with AR glasses, Mudra brings neural input into everyday life.

This early adoption isn’t just validation — it’s acceleration. With real users engaging in real environments, the company is learning fast, improving faster, and shaping a product that grows more refined with every interaction.

Mudra Band

Mudra Band is the company’s flagship B2C product, designed as a sleek, aftermarket accessory for the Apple Watch. It uses patented sEMG sensors to detect neural signals from the wrist and translates them into real-time digital commands. This allows users to control and streamline interactions between the iPhone, iPad, MacBook, and Apple TV using familiar micro-gestures like taps, pinches, or swipes — all without touching a screen.

The device features a high-resolution analog front end, IMU integration, adaptive machine learning, and ergonomic form factors for all-day comfort. Users can toggle between multiple Apple devices using the Mudra Band’s dedicated Apple Watch face, enabling a fully connected, touchless experience. The Mudra Band is optimized for low-latency, high-accuracy interactions and supports a wide range of digital applications. The Mudra Band received a CES 2021 Innovation Award.

Mudra Link

Mudra Link expands the company’s reach beyond the Apple ecosystem, offering compatibility with Android, Windows, and AR/XR platforms. The product includes the innovative Gesture Mapper feature, allowing users to assign personalized commands to gestures such as tap, pinch, flick, or twist. This functionality replaces or augments traditional input methods, supporting media controls, pointer input, and full directional mapping. A key feature of Mudra Link is its dual-mode input system (mouse mode or D-pad mode), empowering users to personalize control schemes across devices, operating systems, and user interfaces.

Mudra Link is recognized for its ergonomic design, lightweight build, and plug-and-play ease of use. It supports native integration with AR glasses from leading manufacturers and received a CES 2025 Innovation Award.

Mudra DevKit and Integration

In parallel with its consumer devices, Wearable Devices offers a Mudra Developer Kit (MDK) and integration program for enterprise and OEM partners. The MDK includes full-stack tools (hardware bands, SDK, APIs, and sample code) that allow developers and original equipment manufacturers to embed Mudra’s neural sensing capabilities into their own products and applications. For example, an AR headset maker can integrate Mudra’s sensors to enable native hand-gesture input, or a software developer can use Mudra’s API to track user gestures for novel interactions.

The MDK supports both Android and iOS and even provides real-time neural raw signal monitoring for research and prototyping. This B2B offering not only expands Mudra technology into new environments such as industrial automation, robotics, and gaming peripherals, but also fosters a broader ecosystem of Mudra-powered solutions. By lowering the barrier for others to adopt its AI gesture recognition engine, Wearable Devices accelerates innovation and garners strategic relationships.

The MDK and related licensing offerings illustrate Wearable Devices’ push-pull strategy: selling consumer products today, while seeding ‘Mudra inside’ into other companies’ devices tomorrow.

Market Opportunity & Strategy

Wearable Devices operates at the intersection of neural interfaces, wearable computing, and the rapidly expanding AR/XR sector. According to MarketsandMarkets, the global AR and VR market is projected to grow from $22.12 billion in 2024 to $96.32 billion by 2029, at a CAGR of 34.2%. The rising demand for natural, hands-free input methods positions neural wearables like Mudra as foundational components in spatial computing and smart environments.

Additionally, the health monitoring wearables market is gaining traction as neural biosignals become a promising data source. The company’s LMM (Large Motor Unit Action Potential Model) platform is being explored for predictive health monitoring, cognitive state tracking, and performance analytics. Government-level support, such as advocacy from the U.S. Secretary of Health and Human Services, further validates the sector’s momentum.

Combined with patent-protected technology and strategic alliances with companies like Qualcomm, TCL-RayNeo(TM), and Media Exceed, Wearable Devices is well-positioned to capture value across consumer, enterprise, and healthcare verticals.

The company’s phased market strategy anticipates this:

  • Phase 1 – Enthusiast Consumer Adoption: Introduce Mudra Band as an add-on for Apple Watch (tapping into a passionate user base of early adopters and tech enthusiasts). Achieve proof-of-concept and get market feedback. This phase built brand credibility and seeded a community of users.
  • Phase 2 – Expand Platform & Ecosystem: Launch Mudra Link for all users and open the Mudra SDK to developers and B2B partners. Focus on the XR/AR market and tech-savvy consumers, while enabling enterprise use-cases through the Developer Kit and strategic partnerships. The company is actively showcasing its tech to industry leaders and integrating with their platforms.
  • Phase 3 – Leverage Data & Enter New Verticals: With a growing user base, Wearable Devices is collecting an invaluable dataset of neural signals and usage patterns. If data is the new oil for AI, neural signals will power the next computing revolution — enabling machines to understand human intent in real time. This fuels its Large Motor-Unit Action Potential Model (LMM) – a bio-signal intelligence platform that continuously learns from neural data to improve accuracy and enable new applications. One major new vertical is digital health and wellness: Wearable Devices is adapting its tech to track physiological and cognitive indicators from the wrist. Because the Mudra sensors capture muscle activation signals, they can potentially detect patterns related to stress, fatigue, focus, and even early signs of health conditions before traditional symptoms appear, and Wearable Devices recently announced it is expanding LMM into predictive health monitoring and cognitive analytics. This means the company could offer solutions for workplace productivity (measuring alertness), athletic training (muscle fatigue analytics), or preventive healthcare (flagging neuromuscular irregularities) – vastly broadening its addressable market. Through monitor applications, the vision is to go from controlling devices to also understanding the user, providing actionable bio-insights. The LMM platform’s AI continuously adapts to each individual’s neural profile, enabling truly personalized and proactive applications.
  • Phase 4 – Ubiquitous Adoption via B2B Integration: Finally, Wearable Devices plans to drive mass adoption by aligning with major consumer tech players. By making its Mudra Data Platform available to enterprises, OEMs, and app developers, the company positions itself as the backbone for neural interaction services. By “laying the groundwork for the next neural frontier”, Wearable Devices is ensuring that when the tech giants move to adopt neural input, its platform is the mature, data-rich standard ready to be deployed.

Through these phased efforts, Wearable Devices balances B2C and B2B paths. It generates near-term revenues and user feedback via direct consumer product sales, while simultaneously developing long-term enterprise relationships and intellectual property value. This dual model not only diversifies revenue streams but also reinforces the technology’s credibility: consumer adoption demonstrates demand and usability, which in turn attracts enterprise interest, creating a virtuous cycle.

Leadership Team

Asher Dahan, Chief Executive Officer, co-founded Wearable Devices Ltd. in 2014 and has served as CEO and director since 2016. He is a seasoned executive with proven expertise in strategic planning, project execution, and business leadership. Asher oversees the company’s operations and resources, guiding major corporate decisions and long-term vision. Prior to founding Wearable Devices, he held engineering and leadership roles at Intel Haifa, specializing in high-speed interface validation. He holds a BSc in Electrical Engineering from Ort Braude College.

Guy Wagner, Chief Scientific Officer and President, co-founded Wearable Devices Ltd. in 2014 and has served on its board since inception. As CSO and President, Guy leads the company’s technological innovation and scientific direction. He is the main inventor behind the company’s core technology and brings multidisciplinary expertise in hardware design, biomedical signal processing, embedded programming, and sensor systems. He previously worked at Intel as a hardware engineer and holds a BSc in Electrical Engineering from Ort Braude College.

Leeor Langer, co-founder and CTO since 2016, is a leading expert in algorithms, machine learning, and signal and image processing. He has held senior R&D roles in the medical imaging and digital security sectors, including at Intel, and brings deep academic and industry experience. Leeor has authored several scientific papers and holds a BSc from the Technion and an MSc in Applied Mathematics from Tel Aviv University, graduating cum laude.

For more information, visit the company’s website at https://wwwearabledevices.co.il.

NOTE TO INVESTORS: The latest news and updates relating to WLDS are available in the company’s newsroom at https://ibn.fm/WLDS

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit www.MissionIR.com

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published: https://www.MissionIR.com/Disclaimer

MissionIR
Austin, Texas
www.MissionIR.com
512.354.7000 Office
Editor@MissionIR.com

MissionIR is powered by IBN

Posted in Wearable Devices Ltd. WLDS | Leave a comment